Search research articles
Contact Us
Filters
Showing results (91-100 of 111) with videos related to
Page
of 12
Sort By:
Blood
|
May 9, 2012
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia
William Blum, Sebastian Schwind, Somayeh S Tarighat, et al.
Haematologica
|
May 6, 2017
Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia
Dimitrios Papaioannou, Deedra Nicolet, Stefano Volinia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2011
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study
Klaus H Metzeler, Kati Maharry, Michael D Radmacher, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2014
Expression and prognostic impact of lncRNAs in acute myeloid leukemia
Ramiro Garzon, Stefano Volinia, Dimitrios Papaioannou, et al.
Blood
|
November 20, 2012
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations
Sebastian Schwind, Colin G Edwards, Deedra Nicolet, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 11, 2015
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
Yvonne A Efebera, Susan Geyer, Leslie Andritsos, et al.
Blood
|
October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia
Christopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Blood
|
October 3, 2013
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease
Kelsie M Bernot, John S Nemer, Ramasamy Santhanam, et al.
Blood Advances
|
February 1, 2023
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML
Stéphane de Botton, Pierre Fenaux, Karen Yee, et al.
Blood Advances
|
July 17, 2023
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories
Uma Borate, Fei Yang, Richard Press, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 111) with videos related to
Sort By:
Page
of 12
Blood
|
May 9, 2012
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia
William Blum, Sebastian Schwind, Somayeh S Tarighat, et al.
Haematologica
|
May 6, 2017
Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia
Dimitrios Papaioannou, Deedra Nicolet, Stefano Volinia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2011
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study
Klaus H Metzeler, Kati Maharry, Michael D Radmacher, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 17, 2014
Expression and prognostic impact of lncRNAs in acute myeloid leukemia
Ramiro Garzon, Stefano Volinia, Dimitrios Papaioannou, et al.
Blood
|
November 20, 2012
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations
Sebastian Schwind, Colin G Edwards, Deedra Nicolet, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 11, 2015
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
Yvonne A Efebera, Susan Geyer, Leslie Andritsos, et al.
Blood
|
October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia
Christopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Blood
|
October 3, 2013
Eradicating acute myeloid leukemia in a Mll(PTD/wt):Flt3(ITD/wt) murine model: a path to novel therapeutic approaches for human disease
Kelsie M Bernot, John S Nemer, Ramasamy Santhanam, et al.
Blood Advances
|
February 1, 2023
Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML
Stéphane de Botton, Pierre Fenaux, Karen Yee, et al.
Blood Advances
|
July 17, 2023
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories
Uma Borate, Fei Yang, Richard Press, et al.
Page
of 12